{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:16:26Z","timestamp":1788203786566,"version":"build-2803163510"},"reference-count":16,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"DOI":"10.15420\/ecr.2026.43","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:28:42Z","timestamp":1787682522000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Cardiovascular Care in Frailty: Priorities for Future Research"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-8920","authenticated-orcid":false,"given":"Tu","family":"Nguyen","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/023331s46","id-type":"ROR","asserted-by":"publisher"}],"name":"The George Institute for Global Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Nguyen TN, Woodward M, Butt JH, et al. Optimizing cardiovascular pharmacotherapy in older adults with frailty. Nat Rev Cardiol 2026;23:433\u201343. https:\/\/doi.org\/10.1038\/s41569-025-01244-w; PMID: 41478887. DOI: 10.1038\/s41569-025-01244-w","DOI":"10.1038\/s41569-025-01244-w"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"James K, Jamil Y, Kumar M, et al. Frailty and cardiovascular health. J Am Heart Assoc 2024;13:e031736. https:\/\/doi.org\/10.1161\/JAHA.123.031736; PMID: 39056350. DOI: 10.1161\/JAHA.123.031736","DOI":"10.1161\/JAHA.123.031736"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ijaz N, Buta B, Xue QL, et al. Interventions for frailty among older adults with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2022;79:482\u2013503. https:\/\/doi.org\/10.1016\/j.jacc.2021.11.029; PMID: 35115105. DOI: 10.1016\/j.jacc.2021.11.029","DOI":"10.1016\/j.jacc.2021.11.029"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kim DH, Rockwood K. Frailty in older adults. N Engl J Med 2024;391:538\u201348. https:\/\/doi.org\/10.1056\/NEJMra2301292; PMID: 39115063. DOI: 10.1056\/NEJMra2301292","DOI":"10.1056\/NEJMra2301292"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hubbard RE, O\u2019Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol 2013;69:319\u201326. https:\/\/doi.org\/10.1007\/s00228-012-1387-2; PMID: 22965651. DOI: 10.1007\/s00228-012-1387-2","DOI":"10.1007\/s00228-012-1387-2"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Yao A, Gao L, Zhang J, et al. Frailty as an effect modifier in randomized controlled trials: a systematic review. J Gen Intern Med 2024;39:1452\u201373. https:\/\/doi.org\/10.1007\/s11606-024-08732-8; PMID: 38592606. DOI: 10.1007\/s11606-024-08732-8","DOI":"10.1007\/s11606-024-08732-8"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Rockwood K, Theou O. Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr J 2020;23:210\u20135. https:\/\/doi.org\/10.5770\/cgj.23.463; PMID: 32904824. DOI: 10.5770\/cgj.23.463","DOI":"10.5770\/cgj.23.463"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Erusalimsky JD. The biological mechanisms of frailty: focusing on cellular senescence. Eur Cardiol 2026;21:e16. https:\/\/doi.org\/10.15420\/ecr.2025.81; PMID: 42005598. DOI: 10.15420\/ecr.2025.81","DOI":"10.15420\/ecr.2025.81"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Evans NR, Bhakta S, Zeicu C, et al. Frailty and cardiovascular risk. Eur Cardiol 2026;21:e22. https:\/\/doi.org\/10.15420\/ecr.2026.09; PMID: 42170193. DOI: 10.15420\/ecr.2026.09","DOI":"10.15420\/ecr.2026.09"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Talha KM, Pandey A, Fudim M, et al. Frailty and heart failure: state-of-the-art review. J Cachexia Sarcopenia Muscle 2023;14:1959\u201372. https:\/\/doi.org\/10.1002\/jcsm.13306; PMID: 37586848. DOI: 10.1002\/jcsm.13306","DOI":"10.1002\/jcsm.13306"},{"key":"ref10","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368; PMID: 34447992."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 2022;145:e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063; PMID: 35363499. DOI: 10.1161\/CIR.0000000000001073","DOI":"10.1161\/CIR.0000000000001073"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"NHFA CSANZ Heart Failure Guidelines Working Group, Atherton JJ, Sindone A, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ 2018;27:1123\u2013208. https:\/\/doi.org\/10.1016\/j.hlc.2018.06.1042; PMID: 30077227. DOI: 10.1016\/j.hlc.2018.06.1042","DOI":"10.1016\/j.hlc.2018.06.1042"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Duong MH, Gulati M, Goyal P, et al. Clinical pharmacology of heart failure in frailty. Eur Cardiol 2026;21:e35. https:\/\/doi.org\/10.15420\/ecr.2025.42. DOI: 10.15420\/ecr.2025.42","DOI":"10.15420\/ecr.2025.42"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Torre I, Tinti L, Amore L, et al. Frailty meets cardio-oncology: a new frontier in personalised cancer care. Eur Cardiol 2026;21:e04. https:\/\/doi.org\/10.15420\/ecr.2025.41; PMID: 41766769. DOI: 10.15420\/ecr.2025.41","DOI":"10.15420\/ecr.2025.41"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Amsalu E, Nguyen TV, Klimis H, et al. The role of frailty in cardio-oncology and its challenges. Eur Cardiol 2025;20:e35. https:\/\/doi.org\/10.15420\/ecr.2025.57; PMID: 41446825. DOI: 10.15420\/ecr.2025.57","DOI":"10.15420\/ecr.2025.57"}],"container-title":["European Cardiology Review"],"original-title":[],"link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2026.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:01:19Z","timestamp":1788202879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2026.43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":16,"URL":"https:\/\/doi.org\/10.15420\/ecr.2026.43","relation":{},"ISSN":["1758-3756","1758-3764"],"issn-type":[{"value":"1758-3756","type":"print"},{"value":"1758-3764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"e48"}}